Vantage logo

Six burning Otezla questions

Planned divestment of Celgene’s psoriasis blockbuster means instant cashback for Bristol, a result the markets see as a win-win-win.

Vantage logo

Almirall spots an opportunity

The Spanish group shows again that there is a future in dermatology, but its Allergan deal really depends on the fate of one asset.